华润医药(03320)：东阿阿胶上半年股东应占净利润8.18亿元，同比增加10.74%

Core Viewpoint - China Resources Pharmaceutical (华润医药) announced the interim report of Dong'e Ejiao for the six months ending June 30, 2025, highlighting significant revenue and profit growth [1] Financial Performance - The company achieved total operating revenue of RMB 3.051 billion, representing a year-on-year increase of 11.02% [1] - Net profit attributable to shareholders reached RMB 818 million, reflecting a year-on-year growth of 10.74% [1] - Basic earnings per share were reported at RMB 1.27 [1] Dividend Distribution - The company proposed a cash dividend of RMB 12.69 per 10 shares (including tax) [1]